Virological Breakthrough: A Risk Factor for Loss to Followup in a Large Community-Based Cohort on Antiretroviral Therapy
Figure 1
A flow diagram describing the cohort with virological breakthrough (>1000 copies/mL) as a subset of ART-naïve adults commencing treatment at the HCTC and subsequent outcomes.